feed,title,long_url,short_url
Benzinga,Novartis' Prostate Cancer Radioligand Therapy Extended Overall Survival by Four Months,https://benzinga.com/general/biotech/21/06/21415069/novartis-prostate-cancer-radioligand-therapy-extended-overall-survival-by-four-months,https://j.mp/3wVUYZq
